Springer Timothy A's Form 4 filing
Cartesian Therapeutics, Inc. (RNAC) · filed Oct 4, 2024
- Accession no.
- 0001453687-24-000115
- Filed
- Oct 4, 2024
- Trade date
- Oct 2-4, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 13 non-derivative transactions and 3 derivative transactions. Open-market purchases total $4.29M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Springer Timothy ACIK 0001055624 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2024 | Common Stock | JOtherAcquired | +1,801,314 | –F1 | – | 7,818,045 | Direct | |
| Oct 2, 2024 | Common Stock | PPurchaseAcquired | +5,514 | $17.38F2 | +$95,833.32 | 7,823,559 | Direct | |
| Oct 2, 2024 | Common Stock | JOtherDisposed | −2,119,193 | –F1 | – | 529,798 | Indirect | |
| Oct 2, 2024 | Common Stock | JOtherAcquired | +317,879 | –F1 | – | 330,695 | Indirect | |
| Oct 3, 2024 | Common Stock | PPurchaseAcquired | +29,847 | $18.25F4 | +$544,707.75 | 7,853,406 | Direct | |
| Oct 3, 2024 | Common Stock | PPurchaseAcquired | +10,249 | $19.01F5 | +$194,833.49 | 7,863,655 | Direct | |
| Oct 3, 2024 | Common Stock | PPurchaseAcquired | +50,489 | $20.18F6 | +$1,018,868.02 | 7,914,144 | Direct | |
| Oct 3, 2024 | Common Stock | PPurchaseAcquired | +21,278 | $21.17F7 | +$450,455.26 | 7,935,422 | Direct | |
| Oct 3, 2024 | Common Stock | PPurchaseAcquired | +8,043 | $21.86F8 | +$175,819.98 | 7,943,465 | Direct | |
| Oct 4, 2024 | Common Stock | PPurchaseAcquired | +9,892 | $21.35F9 | +$211,194.2 | 7,953,357 | Direct | |
| Oct 4, 2024 | Common Stock | PPurchaseAcquired | +48,880 | $22.35F10 | +$1,092,468 | 8,002,237 | Direct | |
| Oct 4, 2024 | Common Stock | PPurchaseAcquired | +16,650 | $23.57F11 | +$392,440.5 | 8,018,887 | Direct | |
| Oct 4, 2024 | Common Stock | PPurchaseAcquired | +4,879 | $23.93F12 | +$116,754.47 | 8,023,766 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Pro rata distribution for no consideration from TAS Partners LLC to the reporting person or the reporting person's spouse, as the case may be. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.
Referenced by the price of 3 transactions in Table I and 3 transactions in Table II.
- F2
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $17.17 to $17.50. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $17.76 to $18.75. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $18.76 to $19.74. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $19.77 to $20.70. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $20.78 to $21.77. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $21.80 to $22.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F9
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $20.87 to $21.86. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F10
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $21.87 to $22.8626. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F11
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $22.87 to $23.8699. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F12
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $23.87 to $24.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.